Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2012
08/22/2012EP2488181A1 Polymorphs of pardoprunox
08/22/2012EP2488180A2 Pharmaceutical compositions for the treatment/prophylaxis of non-alcoholic fatty liver disease
08/22/2012EP2488179A2 Nrf2 inhibitors and use thereof
08/22/2012EP2488178A1 Combinations of a pi3k inhibitor and a mek inhibitor
08/22/2012EP2488177A1 Filamin a binding anti-inflammatory and analgesic
08/22/2012EP2488176A1 Rhodacyanine derivative and pharmaceutical composition for treating leishmaniasis
08/22/2012EP2488175A2 Pharmaceutical compositions
08/22/2012EP2488174A2 Treatment of suicidal ideation or behavior using inhibitors of nicotinic acetylcholine receptors
08/22/2012EP2488173A1 Delayed release compositions
08/22/2012EP2488172A2 Dendrimer compositions and methods of synthesis
08/22/2012EP2488171A2 Emesis treatment
08/22/2012EP2488170A1 Compositions comprising tramadol and celecoxib in the treatment of pain
08/22/2012EP2488169A1 Co-crystals of tramadol and coxibs
08/22/2012EP2488168A1 Combination therapy treatment for viral infections
08/22/2012EP2488167A2 Carbohydrate entrapped active agent delivery composition and articles using the same
08/22/2012EP2488163A1 A delayed release pharmaceutical composition of mesalamine
08/22/2012EP2488162A2 Extended release pharmaceutical compositions of paliperidone and processes of preparation thereof
08/22/2012EP2488161A2 Anti-misuse solid oral dosage form provided having a modified specific release profile
08/22/2012EP2488160A1 Liposomal amphotericin formulation comprising cholesterol for treating fungal infections
08/22/2012EP2488159A2 Emergency contraceptive
08/22/2012EP2488158A1 Improved medicinal aerosol formulations
08/22/2012EP2488157A1 Improved formulations
08/22/2012EP2488156A1 Compositions and methods for mild sedation, anxiolysis and analgesia in the procedural setting
08/22/2012EP2488033A1 Combination
08/22/2012EP2488032A1 Prostaglandin transporter inhibitors and uses thereof
08/22/2012EP2488031A1 Diaryl ether derivatives as notch sparing gamma secretase inhibitors
08/22/2012EP2488029A1 Methods and compositions for deterring abuse
08/22/2012EP2488027A1 Thiazolidinedione energy restriction-mimetic agents
08/22/2012EP2488026A1 The use of a par-1 antagonist in combination with a p2y12adp receptor antagonist for inhibition of thrombosis
08/22/2012EP2488025A1 Sepiapterin reductase inhibitors for the treatment of pain
08/22/2012EP2488023A2 Antimicrobial composition
08/22/2012EP2488022A1 Compositions
08/22/2012EP2488020A1 3-substituted compounds for reducing uric acid
08/22/2012EP2324033B1 Isosorbide nitrates having vasodilating activity
08/22/2012EP2238128B1 Heterocyclic pyrazole-carboxamides as p2y12 antagonists
08/22/2012EP2237837B1 (20r)-23,23-difluoro-2-methylene-19-nor-bishomopregnacalciferol-vitamin d analogs
08/22/2012EP2193118B1 Piperidine and piperazine derivatives for treating tumours
08/22/2012EP2189446B1 Novel 4-{3-[4-(3-{4-[amino(butoxycarbonylimino)methyl]phenoxy}propyl)-1-piperidinyl]propoxy]-n'-(butoxycarbonyl)benzamidine crystals
08/22/2012EP2183239B1 Sulfonamides as trpm8 modulators
08/22/2012EP2181095B1 Novel bronchodilating alpha, beta-unsaturated isoquinoline amides
08/22/2012EP2176282B1 8-beta-substituted 16.alpha.-fluoro-estratrienes as selectively active estrogens
08/22/2012EP2176217B1 Amino acid derivatives
08/22/2012EP2155758B1 Tetrahydrofuro[3,4-d]dioxolane compounds for use in the treatment of viral infections and cancer
08/22/2012EP2102226B1 Macrolide compounds endowed with antiinflammatory activity
08/22/2012EP2057145B1 Synthesis of (2s,5r)-5-ethynyl-1-{n-(4-methyl-1-(4-carboxy-pyridin-2-yl)piperidin-4-yl)glycyl}pyrrolidine-2-carbonitrile
08/22/2012EP2046775B1 N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, preparation thereof and therapeutic use thereof
08/22/2012EP2046121B1 Fatty acid pharmaceutical foam
08/22/2012EP2044070B1 Purine derivatives as a2a agonists
08/22/2012EP2044056B1 Pyrimidine derivatives as alk-5 inhibitors
08/22/2012EP2044034B1 Alkyl-pyridazine derivatives as inhibitors of 11 beta hydroxysteroid dehydrogenase type 1(11b-hsd 1)
08/22/2012EP2041117B1 Heterocyclic substituted piperazine compounds with cxcr3 antagonist activity
08/22/2012EP2013169B1 Indole amide derivatives as ep4 receptor antagonists
08/22/2012EP2011488B1 Transdermal patch containing rasagiline for treatment or prophylaxis of nervous system disease and its preparation process
08/22/2012EP2010489B1 Dialkylphenyl compounds having 2 adrenergic receptor agonist and muscarinic receptor antagonist activity
08/22/2012EP2008662B1 Lipolysis stimulator
08/22/2012EP2007386B1 Camptothecin-analog with a novel, flipped lactone-stable, e-ring and methods for making and using same
08/22/2012EP1993547B1 Prodrugs of benzoquinolizine-2-carboxylic acid
08/22/2012EP1979317B1 Benzoisoindole derivatives for the treatment of pain
08/22/2012EP1976836B1 Nitrogen-containing bicyclic heteroaryl compounds for the treatment of raf protein kinase-mediated diseases
08/22/2012EP1966368B1 RNAi-MEDIATED INHIBITION OF IGF-1R FOR TREATMENT OF OCULAR ANGIOGENESIS
08/22/2012EP1963300B1 Benzochromene derivatives for use in liquid crystal media and as therapeutic active substances
08/22/2012EP1940838B1 Triazolopyridine derivatives as inhibitors of lipases and phospholipases
08/22/2012EP1888548B1 Quinoline derivative for the treatment of retinal diseases
08/22/2012EP1881980B1 Novel crystalline forms of tiotropium bromide
08/22/2012EP1841731B1 Substituted aminomethylene sulphonamides, production and use thereof as medicaments
08/22/2012EP1827468B1 Acetylcholinesterase Inhibitors and leuprolide acetate for the treatment of Alzheimer's disease
08/22/2012EP1820798B1 7-membered ring compound, process for producing the same, and medicinal use thereof
08/22/2012EP1817014B1 Method of providing fast relief to a user of a nicotine chewing gum
08/22/2012EP1809302B1 Antisens modulation of integrin alpha-4 expression
08/22/2012EP1800685B1 Steroidal saponin pharmaceutical composition, its preparation method and use
08/22/2012EP1778690B1 Substituted 8-aminoalkoxi-xanthines, method for the production thereof and use thereof as medicaments
08/22/2012EP1768679B1 Modulation of gsk-3beta and method of treating proliferative disorders
08/22/2012EP1742618B1 Liquid oral formulations of ospemifene
08/22/2012EP1732524B1 Methods and compositions for treatment of ion imbalances
08/22/2012EP1715042B1 EPITOPE/PEPTIDE RECOGNIZED BY HLA-A2402-RESTRICTED Ep-CAM-SPECIFIC CTL AND USE OF THE SAME
08/22/2012EP1663252B1 Application assembly for medicaments that are to be applied to the skin and packaging that is used as an application assembly
08/22/2012EP1646425B1 Parasiticidal composition
08/22/2012EP1611115B1 Benzothiazole derivative compounds, compositions and uses
08/22/2012EP1539225B1 Apparatus and methods for use in enzymatic escharotomy in burn induced compartment syndrome
08/22/2012EP1507780B1 Pyrazolo-pyrimidine aniline compounds useful as kinase inhibitors
08/22/2012EP1503777B1 7-Hydroxy chromones as potent antioxidants
08/22/2012EP1487426B1 Methods of inducing terminal differentiation
08/22/2012EP1412326B1 Butyric acid derivatives
08/22/2012EP1401829B1 Novel heterocyclic antibacterial compounds
08/22/2012EP1272528B1 Chitosan and method of preparing chitosan
08/22/2012EP1200431B3 Quinuclidine derivatives and their use as muscarinic m3 receptors ligands
08/22/2012EP1051978B1 Crystallographically stable amorphous cephalosporin compositions and process for producing the same
08/22/2012CN1997622B Polycationic compounds and uses thereof
08/22/2012CN1935146B Anti-cytochrome oxidase P450 inhibitor medicinal composition and its use
08/22/2012CN1867346B Plant part of opuntia and/or its extract in treatment of depression
08/22/2012CN1803787B Hypericum perforatum L. total flavone extracts, its preparation and application
08/22/2012CN1441676B Method of treatment using ligand-immunogen conjugates
08/22/2012CN102648221A Acrylic and/or methacrylic polymer including alpha-tocopherol grafts
08/22/2012CN102648202A 3,6-diazabicyclo[3.1.1]heptanes as neuronal nicotinic acetylcholine receptor ligands
08/22/2012CN102648201A N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-3-(7-tert-butylpyrazolo[1,5-A][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, a dual modulator of chemokine receptor activity, crystalline forms and processes
08/22/2012CN102648200A 8-ethyl-6-(aryl)pyrido[2,3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders
08/22/2012CN102648198A Pyridine derivatives as S1P1/EDG1 receptor modulators
08/22/2012CN102648195A Novel spiropiperidine compounds
08/22/2012CN102648194A Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use
08/22/2012CN102648193A Spirocyclic compounds as modulators of chemokine receptor activity
1 ... 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 ... 7860